PERI: The acquisition of Perion (PERI) by Affle 3i Ltd. for a closing value of $420 million. Perion shareholders will receive cash consideration of $11.70 per share, representing a 34.48% premium over the stock’s last close. (Press Release)
LCII: LCI Industries (LCII) announced that the proposal received from Monomoy to acquire LCI for $101 per share in cash does not constitute a superior proposal. LCI and Patrick (PATK) remain on track to complete the transaction in the first half of 2027.
PCRX: Viatris (VTRS) commenced the tender offer to acquire Pacira BioSciences (PCRX) for $36.50 per share in cash. The offer will expire on November 16, 2026.
Only plus or premium subscribers can access this post.
Subscribe today.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok